SCHEMBL6783805

SCHEMBL6783805

Nc1ccc(-c2cc(N)ccc2O)c(O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.56
CASP1 P29466 3/20 0.50
TSHR P16473 2/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
ALOX15 P16050 3/20 0.47
HSD17B10 Q99714 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MAPK1 P28482 2/20 0.47
KDM4E B2RXH2 4/20 0.45
TDP1 Q9NUW8 4/20 0.45
ALDH1A1 P00352 4/20 0.45
MAPT P10636 3/20 0.45
CYP3A4 P08684 3/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
GAA P10253 3/20 0.45
THRB P10828 2/20 0.45
CASP7 P55210 2/20 0.45
HPGD P15428 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29518540 0.92 PDE10A (0.64) PDE10ACASP1TSHRCA1CA2
SCHEMBL30880219 0.92 PDE10A (0.64) PDE10ACASP1TSHRCA1CA2
SCHEMBL9402506 0.92 PDE10A (0.64) PDE10ACASP1TSHRCA1CA2
SCHEMBL29484239 0.89 CASP1 (0.59) PDE10ACASP1TSHRCA1CA2
SCHEMBL483397 0.89 CASP1 (0.59) PDE10ACASP1TSHRCA1CA2
SCHEMBL6576117 0.89 PDE10A (0.50) PDE10ACASP1TSHRCA1CA2
SCHEMBL5688015 0.89 NPC1 (0.50) PDE10ACASP1TSHRCA1CA2
Ethane SCHEMBL28807032 0.87 PDE10A (0.65) PDE10ACASP1TSHRCA1CA2
Methane SCHEMBL28033104 0.87 CASP1 (0.56) PDE10ACASP1TSHRCA1CA2
SCHEMBL6011315 0.86 PDE10A (0.52) PDE10ACASP1TSHRCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825208-B2 SELECTIVE INHIBITORS OF SERINE PROTEASE ENZYMES, ESPECIALLY FACTOR VIIA; MODULATION OF THE COAGULATION CASCADE. BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-11-30 US claimed
US-20220364002-A1 ASPHALTENE AND PARAFFIN DISPERSANT COMPOSITIONS AND USES THEREOF ECOLAB USA INC. (US) 2022-11-17 US disclosed
US-6749644-B2 DEVELOPER AND COUPLER; WIDE RANGE OF DIFFERENT COLOR SHADES FROM BLOND TO BROWN, PURPLE, VIOLET AND EVEN BLUE AND BLACK; INTENSITY WELLA AKTIENGESELLSCHAFT (DE) 2004-06-15 US disclosed
US-20020166180-A1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2002-11-14 US disclosed
EP-1208077-A1 2-HYDROXY-5-AMINO-BIPHENYL-DERIVATIVES AND OXIDATIVE HAIR COLOURING AGENTS CONTAINING SAID COMPOUNDS Wella Aktiengesellschaft (DE) 2002-05-29 EP disclosed
WO-2002002507-A1 2-HYDROXY-5-AMINO-BIPHENYL-DERIVATIVES AND OXIDATIVE HAIR COLOURING AGENTS CONTAINING SAID COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2002-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020166180-A1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds AHR, KRT18, HMOX2 PDE10A 4026/4885CASP1 1450/4885TSHR 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.